QLY Biotech Group Corp. (LQLY) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
CARRETERA TURISTICA, LUPERON, 12TH KM PUERTO PLATA, 57000 |
| State of Incorp. | NV |
| Fiscal Year End | August 31 |
| Industry (SIC) | 47 - Transportation Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 2/28/2023 Q2 | 11/30/2022 Q1 | 8/31/2022 Q4 | 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1 | 1 | 1 | 5 | |||||
| Cash and cash equivalent | 1 | 1 | 1 | 5 | |||||
| Prepaid expense | 1 | ||||||||
| Total current assets: | 1 | 1 | 1 | 5 | |||||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 0 | 0 | 0 | 0 | |||||
| Intangible assets, net (including goodwill) | 8 | 1 | 1 | 1 | 2 | ||||
| Intangible assets, net (excluding goodwill) | 8 | 1 | 1 | 1 | 2 | ||||
| Other undisclosed noncurrent assets | 0 | ||||||||
| Total noncurrent assets: | 8 | 1 | 1 | 2 | 2 | ||||
| Other undisclosed assets | (0) | ||||||||
| TOTAL ASSETS: | 8 | 2 | 2 | 3 | 7 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4 | 0 | 1 | 2 | |||||
| Accounts payable | 0 | 1 | 2 | ||||||
| Accrued liabilities | 4 | ||||||||
| Due to related parties | ✕ | 17 | 14 | 12 | 12 | ||||
| Other undisclosed current liabilities | 5 | ||||||||
| Total current liabilities: | 8 | 17 | 14 | 13 | 13 | ||||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 8 | 17 | 14 | 13 | 13 | ||||
| Equity | |||||||||
| Equity, attributable to parent | (8) | (15) | (12) | (10) | (6) | ||||
| Common stock | 4 | 4 | 4 | 4 | 4 | 4 | |||
| Additional paid in capital | 47 | 46 | 26 | 26 | 26 | 26 | |||
| Accumulated deficit | (59) | (50) | (45) | (42) | (40) | (36) | |||
| Total equity: | (8) | (15) | (12) | (10) | (6) | ||||
| TOTAL LIABILITIES AND EQUITY: | 2 | 2 | 3 | 7 | |||||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 2/28/2023 Q2 | 11/30/2022 Q1 | 8/31/2022 Q4 | 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 4 | |||||||
| Operating expenses | (9) | (6) | (3) | (2) | (4) | 26 | ||
| Other undisclosed operating income | 30 | 3 | ||||||
| Operating income (loss): | (9) | 23 | (3) | (2) | (4) | 29 | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (32) | |||||||
| Income (loss) from continuing operations: | (9) | 23 | (3) | (2) | (4) | (3) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | 23 | (3) | (2) | (4) | (3) | |
| Other undisclosed net loss | (28) | (30) | ||||||
| Net loss: | (9) | (5) | (3) | (2) | (4) | (33) | ||
| Other undisclosed net income attributable to parent | 34 | |||||||
| Net income (loss) available to common stockholders, diluted: | (9) | (5) | (3) | (2) | (4) | 1 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 2/28/2023 Q2 | 11/30/2022 Q1 | 8/31/2022 Q4 | 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (9) | (5) | (3) | (2) | (4) | (33) | ||
| Other comprehensive loss | (9) | |||||||
| Other undisclosed comprehensive loss | (14) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (18) | (19) | (3) | (2) | (4) | (33) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.